4.7 Article

Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis

Journal

CELL DEATH AND DIFFERENTIATION
Volume 29, Issue 1, Pages 1-13

Publisher

SPRINGERNATURE
DOI: 10.1038/s41418-021-00827-7

Keywords

-

Funding

  1. Natural Science Foundation of China [32071432, 81872888, 81821005, 91753203, 81773018, 71473074]
  2. National Key RAMP
  3. D Program of China [2020YFE020220]
  4. National Science AMP
  5. Technology Major Project Key New Drug Creation and Manufacturing Program [2018ZX09711002-004]
  6. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12050406]
  7. Shanghai Science and Technology Committee [19JC1416300]
  8. Innovative Research Team of High-Level Local Universities in Shanghai [SSMUZDCX20181202]
  9. K. C. Wong Education Foundation

Ask authors/readers for more resources

This study identified phosphorylation-dependent SCF substrates using a quantitative phosphoproteome approach, demonstrating the mechanism by which SCFFBXO22 recognizes a phosphodegron. FBXO22 was shown to mediate BAG3 ubiquitination and degradation, impacting tumor growth, apoptosis, and cell cycle progression.
SKP1-CUL1-F-box (SCF) ubiquitin ligases play fundamental roles in cellular functions. Typically, substrate phosphorylation is required for SCF recognition and subsequent degradation. However, phospho-dependent substrates remain largely unidentified. Here, using quantitative phoshoproteome approach, we performed a system-wide investigation of phospho-dependent SCF substrates. This strategy identified diverse phospho-dependent candidates. Biochemical verification revealed a mechanism by which SCFFBXO22 recognizes the motif XXPpSPXPXX as a conserved phosphodegron to target substrates for destruction. We further demonstrated BAG3, a HSP70 co-chaperone, is a bona fide substrate of SCFFBXO22. FBXO22 mediates BAG3 ubiquitination and degradation that requires ERK-dependent BAG3 phosphorylation at S377. FBXO22 depletion or expression of a stable BAG3 S377A mutant promotes tumor growth via defects in apoptosis and cell cycle progression in vitro and in vivo. In conclusion, our study identified broad phosphorylation-dependent SCF substrates and demonstrated a phosphodegron recognized by FBXO22 and a novel ERK-FBXO22-BAG3 axis involved in tumorigenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available